Amerge side effects by duration, gender and age - a phase IV clinical study of FDA data
Summary:
Side effects are reported by people who take Amerge. Common side effects include drug ineffective among females and drug ineffective among males.
The phase IV clinical study is created by eHealthMe based on 1,303 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
1,303 people who take Amerge and have side effects are studied.
What is Amerge?
Amerge has active ingredients of naratriptan hydrochloride. It is often used in migraine. eHealthMe is studying from 1,364 Amerge users for its effectiveness, alternative drugs and more.
Number of Amerge reports submitted per year:
Amerge side effects by time on the drug *:
Amerge side effects by gender *:
Amerge side effects by age *:
* Approximation only. Some reports may have incomplete information.
Do you take Amerge?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How the study uses the data?
The study is based on naratriptan hydrochloride (the active ingredients of Amerge) and Amerge (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.
Related studies
Alternative drugs to, pros and cons of Amerge:
- Amerge (1,364 reports)
Common Amerge side effects:
- Drug ineffective: 203 reports
- Migraine (headache): 139 reports
- Headache (pain in head): 135 reports
- Fatigue (feeling of tiredness): 112 reports
- Pain: 105 reports
All Amerge side effects from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zWho is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Amitriptyline Hydrochloride and Gout - now
- Cosentyx and Ciclopirox drug interaction - 7 seconds ago
- Ketoconazole and Catheter Site Erythema - 12 seconds ago
- Thalomid and Fungal Nail Infection - 13 seconds ago
- Enablex and Purpura - 18 seconds ago
- Senna and Intestinal Obstruction - 19 seconds ago
- Meloxicam and Myasthenia Gravis Aggravated - 24 seconds ago
- Aranesp and Videx Ec drug interaction - 26 seconds ago
- Avastin and Kidney Infection (Pyelonephritis) - 27 seconds ago
- Magnesium Sulfate and Bronchiectasis - 30 seconds ago